Table S8. Complete blood counts in patients with single circulating tumor cells and circulating tumor cell clusters. The table shows complete blood counts in patients in whom only single circulating tumor cells (single CTC) or also clustered circulating tumor cells (CTC clusters) were found. Abbreviations: CA 15-3 Cancer antigen 15-3, CRP C-reactive protein, HCT Hematocrit, HGB Hemoglobin, LDH Lactate dehydrogenase, LUC Large unstained cells, MCH Mean corpuscular hemoglobin, MCHC Mean corpuscular hemoglobin concentration, MCV Mean corpuscular volume, MPV Mean platelet volume, PLT Platelets, RBC Red blood cells, WBC White blood cells. (XLSX 10 kb
Clinical response rate and pathological response rate to neoadjuvant chemotherapy. (DOCX 11 kb
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Table S7. Clinical features of patients with single circulating tumor cell and circulating tumor cel...
Table S4. Therapy evaluation in patients with circulating tumor cells. The table shows the types of ...
Table S5. Bisphosphonates or denosumab treatment. The table shows whether bisphosphonates or denosum...
Figure S1. Circulating tumor cell (CTC) capture strategy. (a) Schematic drawing showing the size-bas...
Figure S2. Progression-free survival of patients who were treated or not with denosumab. Kaplan-Meie...
Table S3. Patient characteristics. The table shows the characteristics of the 73 patients included i...
Table S6. Clinical features of patients who were treated or not with denosumab. The table shows clin...
Table S1. Drug classification. The table shows the drug classification used for the analysis, groupi...
Table S2. Variable classification and statistical test applied. The table shows the type of variable...
Presenting enumeration of different CD45neg subgroups, as assessed by FACS, in blood samples obtaine...
Abstract Background The presence of circulating tumor cells (CTCs) in patients with breast cancer co...
Figure S4. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1...
Clinical response rate and pathological response rate to neoadjuvant chemotherapy. (DOCX 11 kb
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb
Table S7. Clinical features of patients with single circulating tumor cell and circulating tumor cel...
Table S4. Therapy evaluation in patients with circulating tumor cells. The table shows the types of ...
Table S5. Bisphosphonates or denosumab treatment. The table shows whether bisphosphonates or denosum...
Figure S1. Circulating tumor cell (CTC) capture strategy. (a) Schematic drawing showing the size-bas...
Figure S2. Progression-free survival of patients who were treated or not with denosumab. Kaplan-Meie...
Table S3. Patient characteristics. The table shows the characteristics of the 73 patients included i...
Table S6. Clinical features of patients who were treated or not with denosumab. The table shows clin...
Table S1. Drug classification. The table shows the drug classification used for the analysis, groupi...
Table S2. Variable classification and statistical test applied. The table shows the type of variable...
Presenting enumeration of different CD45neg subgroups, as assessed by FACS, in blood samples obtaine...
Abstract Background The presence of circulating tumor cells (CTCs) in patients with breast cancer co...
Figure S4. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1...
Clinical response rate and pathological response rate to neoadjuvant chemotherapy. (DOCX 11 kb
Table S1. Levels of peripheral blood lymphocytes of different subtypes do not differ in breast cance...
Figure S1. CTC count as a continuous variable in relation to presence of CTC clusters. (PDF 182 kb